Lisata Therapeutics
LSTA
51 hedge funds and large institutions have $13.9M invested in Lisata Therapeutics in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 17 closing their positions.
52% more capital invested
Capital invested by funds: $9.14M → $13.9M (+$4.71M)
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
0% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 17
2% less funds holding
Funds holding: 52 → 51 (-1)
94% less call options, than puts
Call options by funds: $11K | Put options by funds: $190K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.13M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.48M |
| 3 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$2.48M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$538K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.54M |
| 2 |
State Street
Boston,
Massachusetts
|
-$690K |
| 3 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$174K |
| 4 |
Bank of New York Mellon
New York
|
-$150K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$122K |
LSTA Hedge Fund Activity: Q2 2015 in Review
51 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q2 2015, worth a combined $13.9M — up 52% from $9.14M a quarter earlier.
Fund positioning in LSTA was balanced in Q2 2015: 17 funds opened new positions, 17 closed out, 16 added to existing stakes and 14 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $6.13M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.54M.
- 51 institutional investors held Lisata Therapeutics (LSTA) as of Q2 2015, down from 52 in Q1 2015.
- Funds reported $13.9M of Lisata Therapeutics stock for Q2 2015, up 52% quarter-over-quarter.
- 17 funds opened new Lisata Therapeutics positions in Q2 2015 and 17 closed out, a net change of 0 holders.
- The largest Lisata Therapeutics buyer in Q2 2015 was Great Point Partners, an estimated $6.13M added.
- The largest Lisata Therapeutics seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.54M sold.
Based on aggregated 13F filings for Q2 2015.